Reply to: "Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease"

J Hepatol. 2020 Dec;73(6):1582-1583. doi: 10.1016/j.jhep.2020.08.007. Epub 2020 Sep 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fibrosis
  • Humans
  • Liver Cirrhosis / diagnosis
  • Liver Function Tests
  • Non-alcoholic Fatty Liver Disease* / diagnosis
  • Non-alcoholic Fatty Liver Disease* / therapy